Scarica l'app Stockscreener
10.40
7.24%
-0.85
Dopo l'orario di chiusura:
10.29
-0.11
-1.06%
Precedente Chiudi:
$11.25
Aprire:
$11.34
Volume 24 ore:
2.61M
Relative Volume:
1.64
Capitalizzazione di mercato:
$923.25M
Reddito:
$67.48M
Utile/perdita netta:
$-278.67M
Rapporto P/E:
-3.2731
EPS:
-3.1774
Flusso di cassa netto:
$-70.70M
1 W Prestazione:
+16.46%
1M Prestazione:
+12.69%
6M Prestazione:
-12.97%
1 anno Prestazione:
+85.02%
Intervallo 1D:
$10.39
$11.43
Intervallo di 1 settimana:
$8.98
$11.52
Portata 52W:
$5.45
$12.49
Kura Oncology Inc Stock (KURA) Company Profile
Nome
Kura Oncology Inc
Settore
Industria
Telefono
(858) 500-8800
Indirizzo
4930 DIRECTORS PLACE, SUITE 500, SAN DIEGO, CA
Compare KURA vs VRTX, REGN, ARGX, ALNY, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
KURA
Kura Oncology Inc
|
10.40 | 998.71M | 67.48M | -278.67M | -70.70M | -3.1774 |
VRTX
Vertex Pharmaceuticals Inc
|
435.92 | 110.28B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
634.42 | 66.98B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
808.61 | 50.15B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
295.50 | 39.71B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
154.89 | 32.22B | 742.00K | -1.37B | -1.07B | -7.0731 |
Kura Oncology Inc Stock (KURA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-14 | Iniziato | Lake Street | Buy |
| 2025-09-04 | Iniziato | Guggenheim | Neutral |
| 2025-02-06 | Downgrade | BTIG Research | Buy → Neutral |
| 2024-10-24 | Iniziato | UBS | Buy |
| 2024-10-14 | Downgrade | Stifel | Buy → Hold |
| 2023-12-22 | Iniziato | Mizuho | Buy |
| 2023-08-11 | Iniziato | BofA Securities | Buy |
| 2023-07-27 | Iniziato | Scotiabank | Sector Perform |
| 2023-05-17 | Iniziato | BTIG Research | Buy |
| 2023-01-31 | Iniziato | Stifel | Buy |
| 2022-07-12 | Iniziato | Cantor Fitzgerald | Overweight |
| 2022-02-15 | Iniziato | Jefferies | Buy |
| 2021-05-05 | Ripresa | Credit Suisse | Outperform |
| 2021-04-26 | Ripresa | Credit Suisse | Outperform |
| 2020-12-07 | Reiterato | H.C. Wainwright | Buy |
| 2020-12-03 | Iniziato | Stifel | Buy |
| 2020-11-05 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2020-07-07 | Iniziato | Credit Suisse | Outperform |
| 2020-05-05 | Iniziato | Barclays | Overweight |
| 2019-07-18 | Iniziato | Deutsche Bank | Buy |
| 2018-11-09 | Iniziato | Piper Jaffray | Overweight |
| 2018-08-01 | Iniziato | H.C. Wainwright | Buy |
| 2016-10-13 | Ripresa | Leerink Partners | Outperform |
| 2016-01-22 | Iniziato | JMP Securities | Mkt Outperform |
| 2015-12-30 | Iniziato | Oppenheimer | Outperform |
| 2015-12-16 | Iniziato | Citigroup | Buy |
Mostra tutto
Kura Oncology Inc Borsa (KURA) Ultime notizie
KURA: Strong launch and clinical data drive optimism for growth in AML and solid tumor markets - TradingView
KURA: Strong launch and robust clinical data position therapies for major growth in AML and solid tumors - TradingView
Kura Oncology reports strong tumor shrinkage with darlifarnib + adagrasib in KRAS G12C-mutated cancers. - Pluang
KURA: Promising Results from FIT-001 Trial of Darlifarnib - GuruFocus
Kura Oncology reports tumor shrinkage in cancer drug trial - Investing.com
Kura Oncology reports tumor shrinkage in cancer drug trial By Investing.com - Investing.com Canada
Kura Oncology Reports Promising Phase 1 Results for Darlifarnib in Combination with Adagrasib in KRAS G12C-Mutated Tumors - Quiver Quantitative
Experimental drug combo shrinks tumors in 77% of advanced cancer patients - Stock Titan
Kura Oncology’s SWOT analysis: biotech stock faces launch test By Investing.com - Investing.com India
Kura Oncology’s SWOT analysis: biotech stock faces launch test - Investing.com UK
Insider Sell Alert: Brian Powl Sells 10,000 Shares of Kura Oncol - GuruFocus
Kura Oncology (KURA) CCO sells 10,000 shares in planned trade - Stock Titan
KURA Stock Price, Quote & Chart | KURA ONCOLOGY INC (NASDAQ:KURA) - ChartMill
KURA (NASDAQ: KURA) files Form 144 reporting proposed sale of 10,000 RSUs - Stock Titan
symbol__ Stock Quote Price and Forecast - CNN
Kura Oncology COO Kathleen Ford sells $20,482 in stock By Investing.com - Investing.com South Africa
Insider Sell: Brian Powl Sells Shares of Kura Oncology Inc (KURA) - GuruFocus
Kura Oncology COO Kathleen Ford sells $20,482 in stock - Investing.com
Kathleen Ford Sells 2,257 Shares of Kura Oncology Inc (KURA) - GuruFocus
Kura Oncology (KURA) CCO sells 339 shares while retaining 183,614 - Stock Titan
Kura Oncology (KURA) COO sells 2,257 shares under pre-set trading plan - Stock Titan
[Form 4] Kura Oncology, Inc. Insider Trading Activity - Stock Titan
KURA News | KURA ONCOLOGY INC (NASDAQ:KURA) - ChartMill
[144] Kura Oncology, Inc. SEC Filing - Stock Titan
Kura Oncology to Present at TD Cowen 7th Annual Oncology Innovation Summit - The Manila Times
Kura Oncology Q1 earnings call highlights - MSN
Kura Oncology’s SWOT analysis: stock faces launch challenges despite FDA approval - Investing.com UK
Kura Oncology’s SWOT analysis: biotech stock faces launch challenges - Investing.com
Kura Oncology’s SWOT analysis: biotech stock faces launch challenges By Investing.com - Investing.com Nigeria
Earnings call transcript: Kura Oncology Q1 2026 revenue miss overshadows stable EPS - Investing.com UK
Some Analysts Just Cut Their Kura Oncology, Inc. (NASDAQ:KURA) Estimates - Yahoo Finance
Kura Oncology stock (US50126D1028): FDA breakthrough nod and pipeline update draw investor focus - AD HOC NEWS
LifeSci Capital Maintains Kura Oncology(KURA.US) With Buy Rating, Maintains Target Price $28 - Moomoo
UBS Group AG Acquires 574,455 Shares of Kura Oncology, Inc. $KURA - MarketBeat
Kura Oncology (NASDAQ:KURA) Rating Increased to Hold at Wall Street Zen - MarketBeat
Kura Oncology Inc (KURA) Stock Price, Quote, News & History - Benzinga
Armistice Capital (KURA) holds 3.74M shares, 4.23% stake via Master Fund - Stock Titan
Kura Oncology Inc Azioni (KURA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.49%
0.12%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):